Friday, July 11, 2025
spot_img

Expert panel recommends Bharat Biotech’s ‘Covaxin’ for emergency use

Date:

Share post:

spot_imgspot_img

 


NEW DELHI:  The Subject Expert Committee of Central Drug Standard Control Organization on Saturday recommended Bharat Biotech’s ‘Covaxin’ for emergency use in India. The final decision on its approval will, however, be taken by the Drug Controller General of India (DCGI).

The committee of experts assessing Coronavirus vaccines had called Hyderabad-based Bharat Biotech for a meeting in the afternoon today, a day after the firm was asked to present more data to get a nod, a top source said on Saturday.

On Friday, the Subject Expert Committee of the Central Drug Standard Control Organisation (CDSCO) had held that the data provided by Bharat Biotech for its Coronavirus vaccine is not sufficient for grant of emergency use approval and asked for more information.

The expert committee, tasked with vetting Covid-19 vaccine proposals, had convened a meeting to take a call on emergency use authorisation sought by the Serum Institute of India and Bharat Biotech for their respective vaccine candidates.

Notably, the panel recommended emergency licensure for the Serum Institute of India-manufactured ‘Covishield’. It become the first vaccine to secure recommendation for emergency use in India. The nod of the DCGI is, however, awaited on the recommendation.

The Pune-based Serum Institute has partnered with Oxford-AstraZeneca for conducting clinical trials and manufacturing ‘Covishield’ while Bharat Biotech has collaborated with the Indian Council of Medical Research (ICMR) for ‘Covaxin’.

America’s Pfizer was the first one to apply for the accelerated approval on December 4, followed by the Serum Institute and Bharat Biotech on December 6 and 7, respectively.

The Central government plans to vaccinate nearly 30 crore people in the first phase of drive. It will be offered to one crore healthcare workers, along with 2 crore frontline and essential workers and 27 crore elderly above the age of 50 years most of whom have co-morbidities .

IANS

spot_imgspot_img

Related articles

Djokovic one step closer to title

London, July 10: Novak Djokovic’s search for his personal Holy Grail – a 25th Grand Slam title and...

After routing Real Madrid, PSG eye Chelsea and historic quadruple

East Rutherford, July 10: Wearing their blue, red and white jerseys, Paris Saint-Germain supporters were surrounded by white...

Belinda Bencic storms into semis

London, July 9: Returning to the circuit after the birth of her child, Belinda Bencic continued with her...

Asia Cup in doubt after India, Lanka refuse to attend ACC meeting

Mumbai, July 10: The Asia Cup cricket tournament plunged into further doubt and chaos after India and Sri...